Key Insights

Highlights

Research Leaders

13 sponsors active, led by First Affiliated Hospital of Guangxi Medical University

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03733834Unknown

SD vs. NSD Therapy in Elderly AML

Showing all 1 trials

Research Network

Active Sponsors

  • First Affiliated Hospital of Guangxi Medical University1
  • Third Affiliated Hospital, Sun Yat-Sen University1
  • Nanfang Hospital, Southern Medical University1
  • First Affiliated Hospital of Gannan Medical University1
  • First Affiliated Hospital of Shenzhen University1

Top Investigators

  • Qifa Liu1

    Nanfang Hospital, Southern Medical University

Related Conditions

  • Standard Therapy1

Activity Timeline